Evidence map›Paper›PMID 37644369›Full record

ArticleMolecular biology reports2023

Investigating the relationship between the VNTR variant of the interleukin-1 receptor antagonist gene and coronary in-stent restenosis.

Zeynab Nickhah Klashami, Atoosa Mostafavi, Majid Gholamzadeh Roudbordeh, Ali Abbasi, Pirooz Ebrahimi, Mojgan Asadi, Mahsa M Amoli

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Zeynab Nickhah Klashami *Metabolic Disorders Research Centre, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0002-6241-0692
Atoosa Mostafavi *Department of Cardiology, Faculty of Medicine, Tehran university of medical sciences, Tehran, Iran.
Majid Gholamzadeh RoudbordehDepartment of Cardiology, Faculty of Medicine, Tehran university of medical sciences, Tehran, Iran.ORCID http://orcid.org/0000-0001-7941-4959
Ali AbbasiDepartment of Cardiology, Faculty of Medicine, Tehran university of medical sciences, Tehran, Iran.ORCID http://orcid.org/0000-0003-1929-9535
Pirooz EbrahimiDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata, Italy.
Mojgan AsadiEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0001-5911-1782
Mahsa M AmoliMetabolic Disorders Research Centre, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. amolimm@tums.ac.ir.ORCID http://orcid.org/0000-0002-9168-9223
Tehran University of Medical Sciences · IRUniversity of Calabria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to examine the association between the interleukin-1 receptor antagonist gene (IL-1RN) and coronary in-stent restenosis (ISR) through the analysis of the VNTR variant based on the previously reported results. MATERIALS AND

methodsThe samples were classified into two clearly defined groups: the case group, which comprised 45 patients diagnosed with in-stent restenosis (ISR+), and the control group, which included 60 patients without ISR (ISR-). Polymerase chain reaction (PCR) was performed to examine the 86-bp VNTR variant of the IL-1RN gene.

resultsIn the analysis of six identified groups consisting of variant alleles of 86 base pairs of VNTR of the IL-1RN gene statistically significant difference was observed for the presence of IL1RN*2 allele between cases and controls (p = 0.04, OR; 0.045).

conclusionIndividuals with allele 2 of the IL-1Ra gene may be more predisposed to ISR. This could be due to an imbalance between IL-1Ra and IL-1β which is crucial in preventing the initiation or advancement of inflammatory diseases in specific organs. The observed phenomenon can be characterized by increased production of IL-1β and potential reduction of IL-1Ra as a result of functional VNTR variation in IL-RN gene.

Indexed as

Coronary RestenosisInterleukin 1 Receptor Antagonist ProteinAllelesConstriction, PathologicHumansReceptors, Interleukin-1StentsInterleukin 1 Receptor Antagonist ProteinReceptors, Interleukin-1AtherosclerosisCoronary artery diseaseInterleukin-1 receptor antagonistVariable number of tandem repeats

Identifiers

PMID37644369
OpenAlexW4386241947

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.